Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
about
Transdermal microconduits by microscission for drug delivery and sample acquisitionDesign, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug deliveryTerpene-loaded Liposomes and Isopropyl Myristate as Chemical Permeation Enhancers Toward Liposomal Gene Delivery in Lung Cancer cells; A Comparative StudyTopical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.Fluorescent penetration enhancers for transdermal applications.Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum.Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery.Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery.S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats.Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax.Design principles of chemical penetration enhancers for transdermal drug delivery.In vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity.Discovery of transdermal penetration enhancers by high-throughput screening.Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug deliveryThe influence of the polar head and the hydrophobic chain on the skin penetration enhancement effect of poly(ethylene glycol) derivatives.Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema ModelThe Flip-Flop Diffusion Mechanism across Lipids in a Hybrid Bilayer MembraneEffect of chemical permeation enhancers on nerve blockade.Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris.Chemical penetration enhancers: a patent review.New therapeutic approaches for management of sport-induced muscle strains.Topically applied KTTKS: a review.Azone analogues: classification, design, and transdermal penetration principles.Influence of polyphenols on the physiological processes in the skin.Ex vivo human skin permeation of methylchloroisothiazolinone (MCI) and methylisothiazolinone (MI).Immunohistochemical comparison of whisker pad cutaneous innervation in Swiss Webster and hairless mice.Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination.Cutaneous estradiol permeation, penetration and metabolism in pig and man.Natural sesquiterpene lactones enhance oxacillin and gentamicin effectiveness against pathogenic bacteria without antibacterial effects on beneficial lactobacilli.Enhancement of transdermal delivery of ibuprofen using microemulsion vehicle.Effect of hydroxyl groups and rigid structure in 1,4-cyclohexanediol on percutaneous absorption of metronidazole.Effects of chemical enhancers on human epidermal membrane: Structure-enhancement relationship based on maximum enhancement (E(max)).Transdermal patches: the emerging mode of drug delivery system in psychiatry.A new water-based topical carrier with polar skin-lipids.Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation.Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiencyDevelopment and characterization of oleic acid vesicles for the topical delivery of fluconazole.Non-invasive transdermal delivery route using electrostatically interactive biocompatible nanocapsules.Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model.Novel preparation of transdermal drug-delivery patches and functional wound healing materials.
P2860
Q24793950-A73CEED3-74F0-4BCD-9DE0-63941FE87996Q28537633-B51EBDC5-82CA-4ED9-8A19-914F2CF97F28Q28817640-5B890815-057A-45AE-B819-91096D73A9E0Q30432272-27A9862F-621E-42D7-A098-756F368B6B6FQ30457861-EACC7413-D7E1-48C7-B3FD-1C71DA3F758EQ30764340-7A17131B-E398-4337-B927-9646D2BA2B29Q30949664-AD1860D6-009C-4E85-A1E3-CE9075638712Q33203780-4C632758-67F7-452D-8ACC-1C112E6DF663Q33270945-380787A5-934F-43C2-9B64-372C7381AA10Q33661265-C7FC56C8-1F2A-4BBA-9BAB-E841AAE0F37CQ33935306-60E5C8BC-46F1-43D6-B0C3-35E7A3092336Q33985972-86DD3035-5EA4-4AD3-9451-C50CF97E1E07Q34287633-4E4EB29D-27B5-4834-A291-1A2D328E6581Q34700358-28F715CF-4069-4A35-ADFC-F3078C612B75Q35821910-44D9A6E4-CABA-479C-A8C8-2163CF9D8D9DQ35837675-B043CC8D-043A-4A10-AF7A-AC2CAAE557A9Q37041954-6A19D853-26BD-4A84-AACD-44A5EFA63B34Q37107232-7941B5F8-033E-4DF4-B372-3E421A85BDBAQ37463929-BAF7000B-66B8-438C-8FD3-85252946B34AQ37529814-73E2F4CE-9172-46E2-AF7B-EBDF3C6B0EEFQ37687939-73E8EF74-86F5-4DE0-826E-31BFB09A35D9Q37871068-6074315F-2813-47EE-B9D7-579A4602571CQ38034122-98058DA0-762A-4612-901D-93294D813727Q38317329-858BB309-A1E4-4434-89E5-A666E8860BF8Q38805748-4EB925FC-A506-441B-A0D4-119849120B0CQ39825755-842E9A73-380C-435E-B1E5-7B6348F36566Q40027942-4E34A84E-9558-49CB-923D-A4F91CF4B601Q40460026-FABACF39-B14C-4E0C-B5F3-21CD76A9A254Q41510430-8A334454-7810-4869-AA79-09CE66DE86F4Q41761967-72F0C1B7-F24F-44B3-B9E5-D8D8002F7F32Q41945652-76112586-7580-4512-B15B-0A5523085442Q42143513-8BE150EB-12E2-4FF3-A6BF-85BE51649EBFQ42248837-D54C0DD4-44A1-48FD-ACB9-A40E49BBDD0EQ42529227-EC536601-7CDC-4A52-AB8B-38AC640DED83Q42583117-878C0B17-FE00-482F-ABAD-A12889E5F36BQ42733178-29817A6F-8C9B-4EA9-A011-F393867CCD09Q43126418-FDA70536-B837-4F58-B9B5-3819DC13314CQ43135932-55C82339-B1F0-4FC7-B9F3-4331A24575CAQ43257511-A379E12F-3D3D-4A5D-A754-83E920FA8469Q43257588-4EB23996-4A46-4650-9323-84EA52EE1313
P2860
Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Structure-activity relationshi ...... in transdermal drug delivery.
@ast
Structure-activity relationshi ...... in transdermal drug delivery.
@en
type
label
Structure-activity relationshi ...... in transdermal drug delivery.
@ast
Structure-activity relationshi ...... in transdermal drug delivery.
@en
prefLabel
Structure-activity relationshi ...... in transdermal drug delivery.
@ast
Structure-activity relationshi ...... in transdermal drug delivery.
@en
P2093
P356
P1476
Structure-activity relationshi ...... in transdermal drug delivery.
@en
P2093
Kandimalla K
Kanikkannan N
P304
P356
10.2174/0929867003374840
P577
2000-06-01T00:00:00Z